AUTONOMIX MEDICAL INC (AMIX)
US05330T1060 - Common Stock
AUTONOMIX MEDICAL INC
NASDAQ:AMIX (12/23/2024, 11:47:04 AM)
3.44
-0.16 (-4.44%)
Company Profile
Autonomix Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in The Woodlands, Texas and currently employs 5 full-time employees. The company went IPO on 2024-01-29. Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. The company is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Company Info
AUTONOMIX MEDICAL INC
21 Waterway Ave, Suite 300
The Woodlands TEXAS
P: 18322777816
Employees: 7
Website: https://autonomix.com/
AMIX News
4 hours ago - Autonomix Medical, Inc.Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner SegmentTHE WOODLANDS, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company...
4 days ago - Autonomix Medical, Inc.Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and QualityContinued efforts to build team and infrastructure required to support clinical and regulatory initiatives in anticipation of the FDA approval process for...
18 days ago - Autonomix Medical, Inc.Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the source ...
a month ago - Autonomix Medical, Inc.Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment OptionTHE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company...
a month ago - Autonomix Medical, Inc.Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public OfferingTHE WOODLANDS, TX, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company...
a month ago - Autonomix Medical, Inc.Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate UpdateOngoing proof-of-concept (PoC) clinical trial in pain associated with pancreatic cancer; Preliminary results demonstrate 100% of the lead-in patient...
AMIX Twits
Here you can normally see the latest stock twits on AMIX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
